Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
PCVX
PCVX News & Events
-
Add to Watchlist
Trade PCVX
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
PCVX Stock News Today | Earnings, Events & Price Alerts
PCVX News
Wall Street Analysts Adjust Ratings
4d ago
Benzinga
Vaxcyte Reports Q4 and Full-Year 2025 Financial Results and Business Update
5d ago
NASDAQ.COM
Vaxcyte Reports Q4 Losses and Cash Position
6d ago
seekingalpha
Vaxcyte Initiates Phase 3 Trial for VAX-31 Vaccine
Feb 12 2026
NASDAQ.COM
Vaxcyte Prices Public Offering at $550 Million
Jan 30 2026
Newsfilter
Vaxcyte Initiates Phase 3 Trials for VAX-31, Market Cap Around $7 Billion
Jan 23 2026
Benzinga
Vaxcyte Advances VAX-31 Vaccine with 95% Coverage for Adults
Jan 23 2026
NASDAQ.COM
Stocks to Consider Buying in 2026: Insights from Our Roundtable Experts, Including DoorDash and LVMH
Jan 16 2026
Barron's
Show More News
PCVX Events
No data
PCVX Monitor News
Vaxcyte Prices Public Offering at $550 Million
Feb 02 2026
Vaxcyte Inc Crosses Down 5-Day SMA Amid Market Declines
Dec 01 2025
PCVX Earnings Analysis
Vaxcyte Inc Earnings: Strategic Growth and Financial Outlook- Intellectia AI™
1 years ago
People Also Watch
